|
SLC30A5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.333900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.802500E-02 |
| Normal-vs-Stage2 |
4.070600E-01 |
| Normal-vs-Stage3 |
1.121690E-02 |
| Normal-vs-Stage4 |
3.277800E-02 |
| Stage1-vs-Stage2 |
7.574200E-01 |
| Stage1-vs-Stage3 |
1.996010E-01 |
| Stage1-vs-Stage4 |
3.909600E-01 |
| Stage2-vs-Stage3 |
2.846200E-01 |
| Stage2-vs-Stage4 |
4.509400E-01 |
| Stage3-vs-Stage4 |
7.212800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.286000E-02 |
| Normal-vs-AfricanAmerican |
2.238100E-04 |
| Normal-vs-Asian |
3.331600E-01 |
| Caucasian-vs-AfricanAmerican |
7.140200E-03 |
| Caucasian-vs-Asian |
8.531400E-01 |
| AfricanAmerican-vs-Asian |
4.166600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.947500E-02 |
| Normal-vs-Female |
4.209700E-02 |
| Male-vs-Female |
8.212600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.218050E-03 |
| Normal-vs-Age(41-60Yrs) |
1.732240E-02 |
| Normal-vs-Age(61-80Yrs) |
1.687630E-01 |
| Normal-vs-Age(81-100Yrs) |
2.869600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.059030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.581800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.358000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.187040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.109400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.028000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.598620E-01 |
| Normal-vs-Grade 2 |
3.027800E-01 |
| Normal-vs-Grade 3 |
9.722900E-03 |
| Normal-vs-Grade 4 |
6.156700E-04 |
| Grade 1-vs-Grade 2 |
2.740600E-01 |
| Grade 1-vs-Grade 3 |
9.689000E-01 |
| Grade 1-vs-Grade 4 |
4.993200E-01 |
| Grade 2-vs-Grade 3 |
3.826400E-02 |
| Grade 2-vs-Grade 4 |
5.344600E-03 |
| Grade 3-vs-Grade 4 |
1.389030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.665200E-01 |
| Normal-vs-ccB subtype |
1.009730E-02 |
| ccA subtype-vs-ccB subtype |
1.474170E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.471800E-02 |
| Normal-vs-N1 |
3.483800E-01 |
| N0-vs-N1 |
7.985000E-01 |
|
|
